David Easdown

Testimonial

We’d like to thank David Easdown and the TP Corporate team for their excellent work on our recent acquisitions. Not only does David provide outstanding legal advice to ensure the transactions complete on time and on budget, he understands our business and acquisition strategy and executes it in a commercial manner. I would happily recommend as not just a lawyer but a trusted business adviser.

Colin Caunce

Cohens Chemist

David Easdown

Partner - Corporate

David joined Turner Parkinson from national firm Mills & Reeve LLP in March 2014.

He has 12 years’ of experience acting on a wide range of corporate transactions with a focus on domestic and international M&A. David has significant expertise in working closely with management teams of rapid growth businesses.

He is highly regarded in the M&A market having worked on numerous well-known transactions in the e-commerce, healthcare, logistics and technology sectors and has been ranked as one of the top 3 deals lawyers in the UK for the last 3 years by Experian.

David’s key deals include the sales of Stirling Lloyd plc to NYSE-listed GCP for £73m, Logson Group to W&R Barnett, Inspirepac to Smurfit Kappa for £43.5m and Medical Equipment Supplies and Management to NASDAQ-listed VWR. His work in the pharmacy sector has earnt him a national reputation, having completed hundreds of transactions in that market including the landmark acquisition of Assura Pharmacy by Cohens Chemist for £39.3m.

In his spare time, David enjoys watching sports and spending time with his young family.

Related People